Journals / Eurasian Journal of Emergency Medicine / 2021 / Cilt: 20 - Sayı: 4

The Burden of Chronic Obstructive Lung Disease Disease on the Health System

Pages
269–276
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The elimination and prevention of both internal and external factors that cause the disease, especially without the need for medication, is of great importance in terms of financial and labor loss prevention and reduction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To analyze the cost of patients hospitalized in secondary and tertiary hospitals due to the diagnosis of Chronic Obstructive Lung Disease (COPD) and to draw attention to the cost of COPD and the reasons that increase the cost in our country.
📊
Key Findings & Data:Materials and Methods: This research was carried out in a chest diseases clinic in second and third-level hospitals affiliated with the ministry of health, between 1 January 2018-31 December 2018.
💡
Conclusion & Impact:Conclusion: The elimination and prevention of both internal and external factors that cause the disease, especially without the need for medication, is of great importance in terms of financial and labor loss prevention and reduction.
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: To analyze the cost of patients hospitalized in secondary and tertiary hospitals due to the diagnosis of Chronic Obstructive Lung Disease (COPD) and to draw attention to the cost of COPD and the reasons that increase the cost in our country. Materials and Methods: This research was carried out in a chest diseases clinic in second and third-level hospitals affiliated with the ministry of health, between 1 January 2018-31 December 2018. Demographic features, smoking, duration of hospitalization, length of hospitalization in intensive care, antibiotics used, number of outpatients applied, total hospitalization cost, total costs and duration of antibiotics used were recorded. Costs were stated in Turkish Lira and converted into dollars. Cost data of patients with more than one hospitalization were entered separately. Results: The numbers of men and women were equal in both 2nd level and 3rd level patients. Looking at patients with COPD in both the secondary and tertiary, total hospital cost in patients was significantly higher than those who did not. When the length and number of hospitalization increased, the total cost of the hospital increased significantly. Significant differences were not found between age groups, gender, smoking status, comorbidities, antibiotic use, number of outpatient clinic admissions, and the number of hospitalizations in the last two years in terms of total hospital cost. Conclusion: The elimination and prevention of both internal and external factors that cause the disease, especially without the need for medication, is of great importance in terms of financial and labor loss prevention and reduction.

🔖

Cite This Article

Yeşildağ, K., Aydemir, Ö. (2022). The Burden of Chronic Obstructive Lung Disease Disease on the Health System. Eurasian Journal of Emergency Medicine, Cilt: 20 - Sayı: 4, 269–276. https://ajindex.com/articles/507942

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. GOLD 2017. Global Strategy for the Diagnosis, Management and Prevention of COPD. Available at: http://goldcopd.org/gold-2017-global-strategydiagnosismanagement- prevention-copd/. Accessed September 5, 2018.
  2. National Center for Health Statistics (US). Health, United States, 2015: With Special Feature on Racial and Ethnic Health Disparities. Hyattsville (MD): National Center for Health Statistics (US); 2016 May. Report No.: 2016-1232
  3. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-128
  4. Duffy SP, Criner GJ. Chronic Obstructive Pulmonary Disease: Evaluation and Management. Med Clin North Am. 2019;103:453-61
  5. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, et al. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182:693-718
  6. Mut S, Ağırbaş İ. Hastanelerde Maliyet Analizi: Ankara’da Hizmet Sunan İkinci Basamak Bir Kamu Hastanesi’nde Uygulama. Mehmet Akif Ersoy Üniversitesi Sosyal Bilimler Enstitüsü Dergisi. 2017;9:202-17
  7. Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. Global and regional estimates of COPD prevalence: Systematic review and metaanalysis. J Glob Health. 2015;5:020415
  8. T.C. Sağlık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü. Türkiye kronik hava yolu hastalıklarını (astım - koah) önleme ve kontrol programı (2009 – 2013 Ankara. ISBN: 978-975-590-287-6
  9. Backman BH, Virchow JC, Lundbäck B. COPD in women - New results presented. Respir Med. 2021;176:106238
  10. Perez TA, Castillo EG, Ancochea J, Pastor Sanz MT, Almagro P, Martínez- Camblor P, et al. Sex differences between women and men with COPD: A new analysis of the 3CIA study. Respir Med. 2020;171:106105
  11. Ni H, Xu J. COPD-related Mortality by Sex and Race Among Adults Aged 25 and Over: United States, 2000-2014. NCHS Data Brief. 2016;(256):1-8
  12. Lortet-Tieulent J, Soerjomataram I, López-Campos JL, Ancochea J, Coebergh JW, Soriano JB. International trends in COPD mortality, 1995-2017. Eur Respir J. 2019;54:1901791
  13. López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21:14-23.